In the realm of medical devices, software is not just an enabler but often a lifeline. Patch management for medical device software is a critical process that ensures the security, functionality, and regulatory compliance of these devices. Effective patch management involves systematically deploying and maintaining software updates and patches to address vulnerabilities and enhance the overall performance of devices. Given the sensitive nature of medical devices, which frequently operate in environments where patient safety is paramount, maintaining up-to-date software is essential to mitigate potential risks.
This article delves into the intricacies of patch management, aligning with FDA cybersecurity requirements and other applicable regulations in the US and EU markets.
We have been extensively discussing about cybersecurity-related topics, including cybersecurity risk management, vulnerability disclosure, cybersecurity testing, and much more.
What is Patch Management?
Patch management is the process of identifying, acquiring, testing, deploying, and verifying software updates (patches) to address known vulnerabilities, improve functionality, or enhance performance. For medical devices, patch management is integral to maintaining the device’s secure operation, ensuring compliance with regulatory standards, and safeguarding patient safety.
FDA Requirements for Patch Management
Cybersecurity vulnerabilities can pose significant risks to the safe and effective operation of networked medical devices that utilize off-the-shelf (OTS) software. If these vulnerabilities are not properly addressed, they could have adverse effects on public health. A key concern with OTS software is the necessity for timely software patches to fix newly discovered vulnerabilities. The question arises whether FDA premarket review is required before implementing a software patch to address such vulnerabilities.
Generally, FDA premarket review is not required for the implementation of a SW patch aimed at addressing cybersecurity vulnerabilities. FDA review is typically needed only when a change or modification could significantly impact the safety or effectiveness of a medical device, as outlined in 21 CFR 807.81(a)(3) and 814.39. For medical devices cleared under the 510(k) program, the guidance “Deciding When to Submit a 510(k) for a Change to an Existing Device” clarifies that a new 510(k) submission is necessary if the device has a new or changed indication for use, or if the proposed change could significantly affect the device’s safety or effectiveness. It is possible, though unlikely, that a software patch would require a new 510(k) submission. As with all modifications, the basis for decisions regarding software patches should be thoroughly documented in the design history file, in accordance with 21 CFR 820.3(e) and 820.30(j).
Typically, it is not necessary to report a cybersecurity patch, as the primary purpose of installing software patches is to mitigate the risk associated with cybersecurity vulnerabilities rather than to address health risks posed by the device. Hence, in most instances, there is no obligation to report a cybersecurity patch under 21 CFR Part 806 as long as the change has been assessed and duly documented in the records. However, if the software patch impacts the safety or effectiveness of the medical device, it is imperative to report the correction to the FDA, even if a software maintenance plan is currently in place.
Cybersecurity documentation kit is the right tool to ensure compliance with cybersecurity requirements for active device, including stand-alone software.
299 €
Considerations on the Patch Management Process
Medical device manufacturers support their device life cycle with formal processes in compliance with FDA regulations (and/or other applicable regional authorities). Historically, security patches have been included with each release and typically provided as a cumulative package since the last release. If these patches do not affect or change the intended use of the device, there is no requirement for notification or filing with the primary regulator (e.g., FDA).
However, manufacturers must test and validate the changes to ensure no adverse impact on the device. Many manufacturers have adopted the practice of providing major releases (feature enhancements and cumulative patches), minor updates to the application, and fixes addressing specific, limited issues, which may include cumulative COTS patches.
Medical device manufacturers must support the device lifecycle with formal patch management processes aligned with FDA and EU MDR requirements. Key considerations include:
Patches can be delivered as downloadable software updates, physical media, or manufacturer-issued notifications for customer deployment.
- Patch Release Types:
Major Releases: Include feature enhancements and cumulative patches.
Minor Updates: Address limited application issues.
Cumulative OTS Patches: Include bundled updates to third-party software components.
- Testing and Validation:
Before deployment, all patches must undergo rigorous testing to validate their compatibility and ensure they do not adversely affect the device’s intended use.
Verification and validation activities should follow the manufacturer’s quality management system (QMS).
- Customer Notification
Manufacturers are required to inform customers about patch availability and provide guidance for secure deployment.
Notifications should include details about the patch’s purpose, installation instructions, and potential risks of not applying the update.
- Delivery Methods:
Delivery options for the patches range from a manufactured, deployable patch to a notification that patches have been tested and released. Customers can then deploy the patches following the manufacturer’s recommendations.
Risk Management
Healthcare organizations face a risk tradeoff recognized by the FDA: they may consider the risk of not patching higher than the risk of patching, accepting not only the risk of patching but also the risk of unintended consequences related to the software patch and the devices in use. This decision is challenging for many hospitals or clinics, particularly if they lack the capability or program maturity to make such assessments. The FDA postmarket guidance underscores that healthcare organizations should evaluate their network security and protect their hospital systems. Thus, individual organizations or clinics have a clear responsibility to maintain the secure baseline of the connected medical devices they purchase and deploy on their networks. This reality highlights an area where emerging technology, such as security and lifecycle management platforms, can provide significant support and opportunities for enhancing an organization’s risk management and information technology programs.
Subscribe to 4EasyReg Newsletter
4EasyReg is an online platform dedicated to Regulatory matters within the medical device, information security and AI-Based business.
We offer a wide range of documentation kits to support your compliance efforts towards a wide range of standards and regulations, such as ISO 13485, EU MDR, ISO 27001, ISO 42001 and much more. . Specifically, in our webshop you will find:
- ISO 13485 Documentation / Compliance Kit
- ISO 27001 Documentation / Compliance Kit
- ISO 42001 Documentation / Compliance Kit
- FDA Cybersecurity Documentation
Within our sister platform QualityMedDev Academy, a wide range of online & self-paced training courses is available, such as for example:
- Complaint Handling and Vigilance Reporting
- Artificial Intelligence in Medical Device. Regulatory Requirements
- Unique Device Identification (UDI) Requirements according to EU MDR
- Clinical Evaluation Process According to EU MDR
- Medical Device SW Verification & Validation
- Risk Management for Medical Devices
- Usability Evaluation for Medical Devices
As one of the leading online platforms in the medical device sector, 4EasyReg offers extensive support for regulatory compliance. Our services cover a wide range of topics, from EU MDR & IVDR to ISO 13485, encompassing risk management, biocompatibility, usability, software verification and validation, and assistance in preparing technical documentation for MDR compliance.
Do not hesitate to subscribe to our Newsletter!
